MENU
ARDX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Ardelyx (ARDX) Earnings Date & Reports
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
ARDX is expected to report earnings to fall 76.87% to -3 cents per share on July 30
Q2'26
Est.
$-0.03
Q1'26
Missed
by $0.02
Q4'25
Missed
by $0.02
Q3'25
Beat
by $0.06
Q2'25
Beat
by $0.05
The last earnings report on April 30 showed earnings per share of -15 cents, missing the estimate of -12 cents. With 3.09M shares outstanding, the current market capitalization sits at 1.53B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a developer of therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases
Industry Biotechnology
Profile
Details
Industry
Biotechnology
Address
400 Fifth Avenue
Phone
+1 510 745-1700
Employees
489
Web
https://www.ardelyx.com